Table 3 Clinical and demographical characteristic of the additional validation set of patients (4 CIS and 6 Definite MS).
From: Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells
| Â | Age (Years) | Disease Duration (Years) | Annua Relapse Rate | EDSS | F/M | Yes/No Future IMD Treatment |
|---|---|---|---|---|---|---|
CIS | 24 ± 5.01 | 0.34 ± 0.09 | 6.1 ± 2.05 | 2.58 ± 0.15 | 0/6 | 6/0 |
Definite MS | 36 ± 7.61 | 5.3 ± 2.39 | 1 ± 0.51 | 5.3 ± 2.39 | 2/2 | 3/1 |